Stanford PD Community Blog

Stanford Parkinson's Community
  • Home
You are here: Home / News / New York Times: F.D.A. Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers

New York Times: F.D.A. Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers

April 7, 2017 By Parkinson's Community Help

07GENE2-master768On April 6, the New York Times reports that the FDA will allow 23andMe to sell genetic tests for disease risk to consumers.  According to the article, customers have to specifically ask to be tested for Alzheimer’s and Parkinson’s risk.

New York Times: F.D.A. Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers

Filed Under: News, Research

  • Home

Categories

  • Monthly List – PD Webinars
  • Seminarios web sobre la EP en español
  • Webinars – Announcements & Notes
  • Local Support Groups – Announcements & Notes
  • Events
  • News
  • Research
  • Exercise

Top Pages of the Stanford Parkinson’s Community Outreach Website

  • List of Live, Virtual PD Exercise Classes
  • List of PD Exercise Videos
  • Symptoms of PD
  • For Those Newly Diagnosed
  • Support Resources for PD

Featured Posts

PSP and CBD Overview – Webinar – August 28, 2025

On Thursday, August 28, from 3-4:30pm PT, Stanford behavioral neurologist Niyatee Samudra, MD, will … [Read More...]

Orthostatic Hypotension in Parkinsonian Syndromes – Webinar – August 13, 2025

Join us on Wednesday, August 13, at 2:30pm PT to hear Stanford Neurololgy autonomic specialist … [Read More...]

Please Participate – Survey of the Financial and Social Impact of PD and Atypical Parkinsonism

We invite you to participate in a very important survey, supported in part by the American … [Read More...]

Archive